Rojo Álvaro Jorge, Bermejo Fraile Begoña, Menéndez Torre Edelmiro, Ardanaz Eva, Guevara Marcela, Anda Apiñániz Emma
Servicio de Endocrinología, Complejo Hospitalario de Navarra, IdiSNA, Navarra Institute for Health Research, Pamplona, España.
Servicio de Medicina Preventiva, Complejo Hospitalario de Navarra, IdiSNA, Navarra Institute for Health Research, Pamplona, España.
Endocrinol Diabetes Nutr. 2017 Jun-Jul;64(6):303-309. doi: 10.1016/j.endinu.2017.02.013. Epub 2017 May 11.
The latest published studies show an increased incidence of thyroid cancer worldwide. The aim of this study was to analyze the changes in the incidence of thyroid cancer in Navarra and its clinical presentation regarding sex, histological subtype and size over the last 25 years.
Thyroid cancer incidence rates were calculated on the basis of data from the Cancer Registry of Navarra during 1986-2010. Clinical data were obtained from the historical cohort of the Hospital Registry of Cancer of Navarra, which includes all the new cases of differentiated thyroid carcinoma diagnosed and treated in the public health network of this Community in that period.
The overall incidence of thyroid cancer in Navarra increased over the last 25 years, with an increase in the adjusted rate in men from 2.24 (1986-1990) to 5.85 (2006-2010) per 100,000 population/year (P<.001) and in women from 9.05 to 14.04, respectively (P<.001). This increase occurs only in papillary carcinoma. The clinical characteristics of 739 patients with differentiated thyroid cancer were studied. The mean age at diagnosis increased over the years and the predominance of women (about 80%) remains stable. Mean tumor size decreased over the five-year periods from 30.9 to 22.5mm (P<.001), the proportion of microcarcinomas (T1a) increased from 8.8% to 30% (P<.001) and, despite this increase, there were no statistical differences in the TNM stage at diagnosis during the study period. The distribution of histological variants of papillary and follicular carcinoma did not change over 25 years.
During the period studied, the incidence of thyroid cancer increased in Navarra in both sexes. The increase occurred only in papillary carcinoma, without changes in the distribution of his histological variants. The increase in the proportion of T1a tumors is remarkable, but the TNM stage distribution was maintained. These results suggest an increase in the diagnosis of thyroid microcarcinomas due to changes in clinical practice, without ruling out a real increase in the incidence of papillary carcinoma in Navarra.
最新发表的研究表明,全球甲状腺癌的发病率有所上升。本研究的目的是分析纳瓦拉地区甲状腺癌发病率的变化情况,以及过去25年中其在性别、组织学亚型和肿瘤大小方面的临床表现。
根据纳瓦拉癌症登记处1986 - 2010年的数据计算甲状腺癌发病率。临床数据来自纳瓦拉癌症医院登记处的历史队列,其中包括该时期在该社区公共卫生网络中诊断和治疗的所有分化型甲状腺癌新病例。
在过去25年中,纳瓦拉地区甲状腺癌的总体发病率有所上升,男性的调整发病率从每10万人年2.24(1986 - 1990年)增至5.85(2006 - 2010年)(P <.001),女性则从9.05增至14.04(P <.001)。这种增长仅发生在乳头状癌中。对739例分化型甲状腺癌患者的临床特征进行了研究。诊断时的平均年龄逐年增加,女性的优势比例(约80%)保持稳定。平均肿瘤大小在五年期间从30.9毫米降至22.5毫米(P <.001),微小癌(T1a)的比例从8.8%增至30%(P <.001),尽管有这种增长,但研究期间诊断时的TNM分期并无统计学差异。乳头状癌和滤泡状癌的组织学变体分布在25年中没有变化。
在研究期间,纳瓦拉地区男女甲状腺癌的发病率均有所上升。增长仅发生在乳头状癌中,其组织学变体分布没有变化。T1a肿瘤比例的增加显著,但TNM分期分布保持不变。这些结果表明,由于临床实践的变化,甲状腺微小癌的诊断有所增加,但不排除纳瓦拉地区乳头状癌发病率的实际上升。